Rediff.com » News
Europe watchdog advises suspending 'risky' osteoporosis drug
January 11, 2014
A committee of Europe's medicines watchdog today recommended suspending the use of an osteoporosis drug, saying the risks, including heart attacks, outweighed the benefits.
The drug, Protelos/Osseor, is prescribed for people with the bone-crumbling disease who often suffer debilitating fractures.
A product of French firm Servier Laboratories, the medicine is said to make bones stronger and prevent breaks.